Literature DB >> 20469964

Primary hyperparathyroidism in pregnancy: a diagnostic and therapeutic challenge.

I-L Nilsson1, N Adner, E Reihnér, C Palme-Kilander, G Edstrom, M Degerblad.   

Abstract

The risk of severe complications arising from primary hyperparathyroidism (pHPT) is increased during pregnancy. Gestational pHPT often goes undiagnosed, and by the time it is diagnosed, a majority of women have endured one or more failed pregnancies. During pregnancy, active transport of calcium ions from the mother to the fetus leads to suppression of the fetal parathyroids. When the prenatal pool of calcium is depleted, the newborn may develop neonatal hypocalcemic tetany. The mother, in turn, may suffer from worsening hypercalcemia and a hypercalcemic crisis after delivery. Awareness and confirmation of the diagnosis may be crucial for the outcome. The only definitive treatment of pHPT is parathyroidectomy, which should be recommended in most cases. Our two cases illustrate both the importance of and the difficulty in detecting pHPT during pregnancy, as well as some of the serious complications that may occur during pregnancy and after delivery.

Entities:  

Mesh:

Year:  2010        PMID: 20469964     DOI: 10.1089/jwh.2009.1777

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  4 in total

1.  Primary hyperparathyroidism in pregnancy leading to hypercalcaemic crisis and uraemic encephalopathy.

Authors:  E Nash; P Ranka; G Tarigopula; T Rashid
Journal:  BMJ Case Rep       Date:  2015-03-27

2.  Primary hyperparathyroidism mimicking hyperemesis gravidarum.

Authors:  Brian C Benson; Roy E Guinto; Jonathan R Parks
Journal:  Hawaii J Med Public Health       Date:  2013-01

3.  Pregnancy in multiple endocrine neoplasia type 1 equals multiple complications.

Authors:  Megha Mistry; Manish Gupta; Mandeep Kaler
Journal:  Obstet Med       Date:  2014-05-06

4.  Undiagnosed Primary Hyperparathyroidism and Recurrent Miscarriage: The First Prospective Pilot Study.

Authors:  Aimee DiMarco; Ioannis Christakis; Vasilis Constantinides; Lesley Regan; F Fausto Palazzo
Journal:  World J Surg       Date:  2018-03       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.